Zealand Pharma’s Emmanuel Dulac, fresh from a first US FDA approval for the company’s rescue pen for severe hypoglycaemia in people with diabetes…

Dr Tina Hahn explains how AXON positions itself as a strategic partner for its Danish clients in their scientific communication work, highlights how…

Erik Jylling of the Danish Regions, the organisation charged with healthcare management for each of Denmark's five regions, outlines the advantages…

Data has been collected within Danish healthcare for more than 40 years, extending beyond the national patient registry to include a broad range of…

Copenhagen Capacity is Greater Copenhagen's official organization for investment, promotion, and business development. Its CEO/managing director,…

Danish pharma industry veteran Peter Drøidal highlights how he steered the Danish Novartis affiliate through the COVID-19 pandemic period, the…

Peter Huntley of Medicoindustrien, the industry association for Danish medtech, outlines his vision for the industry, including why a shift to broad,…

Per Jørgensen, deputy director of Copenhagen University Hospital (Rigshospitalet), discusses pandemic management, clinical trial collaborations with…

Petter Hartman of the Medicon Valley Alliance, a non-profit membership organisation spanning the Danish-Swedish life science cluster Medicon Valley,…

Since joining Danish neuroscience specialist Lundbeck as its global CEO in 2018, South African Deborah Dunsire has focused on “revitalising and…

Speaking exclusively to PharmaBoardroom, Lundbeck’s global CEO Deborah Dunsire describes the progress in the strategy she put in place to…

Industry veteran Patrik Forsell oversees Takeda’s operations in Denmark. Here, Forsell talks through how sizeable shifts in the company’s global…